Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Merkel Cell Carcinoma, Unspecified
Renal Cell Carcinoma
Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: zirconium Zr 89 crefmirlimab berdoxam

Sponsor

ImaginAb, Inc.